Two milestones achieved toward small bore access with impella

Danvers, mass.--(business wire)--abiomed (nasdaq: abmd) announces the achievement of two milestones in the development of small bore access for the impella heart pump. the impella ecp heart pump has completed the first stage in its u.s. food and drug administration (fda) early feasibility study (efs) and the fda has granted 510(k) clearance to the impella xr sheath. the impella xr sheath is a low-profile sheath that expands and recoils, allowing for small bore access and closure with the impell
ABMD Ratings Summary
ABMD Quant Ranking